Article
More Eisai/Biogen Alzheimer's drug approvals seen likely despite safety warning
Rating:
0.0
Views:
40
Likes:
1
Library:
1
With U.S. approval of Eisai's and Biogen's Alzheimer's drug Leqembi secured, Wall Street analysts said they expect other region's health regulators to follow suit even if they share similar concerns about a potentially severe side effect.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value